Steris Corp Fourth Quarter Earnings Sneak Peek

Steris Corp (NYSE:STE) will unveil its latest earnings on Tuesday, May 8, 2012. STERIS is a provider of infection prevention and surgical products and services, focused mainly on the critical markets of healthcare, pharmaceutical and research.

Steris Corp Earnings Preview Cheat Sheet

Wall St. Earnings Expectations: The average analyst estimate is for profit of 60 cents per share, a decline of 1.6% from the company’s actual earnings for the year-ago quarter. During the past three months, the average estimate has moved down from 64 cents. Between one and three months ago, the average estimate moved down. It has been unchanged at 60 cents during the last month. Analysts are projecting profit to rise by 1.4% compared to last year’s $2.16.

Past Earnings Performance: The company enters this earnings report having missed estimates the last four quarters. Last quarter, the company fell short of expectations by 2 cents, reporting net income of of 59 cents per share against a mean estimate of profit of 61 cents per share.

Investing Insights: What’s the Future of Microsoft’s Stock?

Wall St. Revenue Expectations: On average, analysts predict $380.4 million in revenue this quarter, a rise of 0.7% from the year-ago quarter. Analysts are forecasting total revenue of $1.39 billion for the year, a rise of 14.9% from last year’s revenue of $1.21 billion.

Analyst Ratings: Analysts seem relatively indifferent about Steris with four of six analysts surveyed maintaining a hold rating.

A Look Back: In the third quarter, profit rose 54.6% to $33.6 million (58 cents a share) from $21.8 million (36 cents a share) the year earlier, but fell short analyst expectations. Revenue rose 8.2% to $355.2 million from $328.3 million.

Key Stats:

On the top line, the company is looking to build on four-straight revenue increases heading into this earnings announcement. Revenue rose 13.7% in the fourth quarter of the last fiscal year, 68.6% in the first quarter and 9.7% in the second quarter before increasing again in the third quarter.

Stock Price Performance: Between February 6, 2012 and May 2, 2012, the stock price rose 87 cents (2.9%), from $30.48 to $31.35. The stock price saw one of its best stretches over the last year between January 12, 2012 and January 20, 2012, when shares rose for six straight days, increasing 5.3% (+$1.48) over that span. It saw one of its worst periods between March 30, 2012 and April 10, 2012 when shares fell for seven straight days, dropping 4.6% (-$1.47) over that span.

(Company fundamentals by Xignite Financials. Earnings estimates provided by Zacks)

Don’t Miss These Additional Hot Stories:

Why Are These Health Stocks Feeling Under the Weather?

What Do Americans Think About Gold?>>

Here’s How to Bet on a Baby Boom>>